Literature DB >> 15711804

Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.

Hüseyin Duyar1, Jörn Dengjel, Katrien L de Graaf, Karl-Heinz Wiesmüller, Stefan Stevanović, Robert Weissert.   

Abstract

Experimental autoimmune encephalomyelitis induced with myelin proteins in DA and LEW.1AV1 rats is a model of multiple sclerosis (MS). It reproduces major aspects of this detrimental disease of the central nervous system. MS is associated with the HLA-DRB1*1501, DRB5*0101, and DQB1*0602 haplotype. DA and LEW.1AV1 rats share the RT1av1 haplotype. So far, no MHC class II peptide motif of RT1.Da molecules has been described. Sequence alignment of the beta chain of the rat MHC class II molecule RT1.Da with human HLA class II molecules revealed strong similarity in the peptide-binding groove of RT1.Da and HLA-DRB1*1501. According to the putative peptide-binding pockets of RT1.Da, after comparison with the pockets of HLA-DRB1*1501, we predicted the peptide motif of RT1.Da. To verify the predicted motif, naturally processed peptides were eluted by acidic treatment from immunoaffinity-purified RT1.Da molecules of lymphoid tissue of DA rats and subsequently analyzed by ESI tandem mass spectrometry. In addition, we performed binding studies with combinatorial nonapeptide libraries to purified RT1.Da molecules. Based on these studies we could define a peptide-binding motif for RT1.Da characterized by aliphatic amino acid residues (L, I, V, M) and of F for the peptide pocket P1, aromatic residues (F, Y, W) for P4, basic residues (K, R) for P6, aliphatic residues (I, L, V) for P7, and aromatic residues (F, Y, W) and L for P9. Both methods revealed similar binding characteristics for peptides to RT1.Da. This data will allow epitope predictions for analysis of peptides, relevant for experimental autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15711804     DOI: 10.1007/s00251-004-0761-3

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  31 in total

Review 1.  The HLA system. First of two parts.

Authors:  J Klein; A Sato
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

2.  Allelic variations in rat MHC class II binding of myelin basic protein peptides correlate with encephalitogenicity.

Authors:  K L de Graaf; R Weissert; P Kjellén; R Holmdahl; T Olsson
Journal:  Int Immunol       Date:  1999-12       Impact factor: 4.823

3.  New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library.

Authors:  B Fleckenstein; H Kalbacher; C P Muller; D Stoll; T Halder; G Jung; K H Wiesmüller
Journal:  Eur J Biochem       Date:  1996-08-15

4.  Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules.

Authors:  H Schild; U Grüneberg; G Pougialis; H J Wallny; W Keilholz; S Stevanović; H G Rammensee
Journal:  Int Immunol       Date:  1995-12       Impact factor: 4.823

5.  Peptide length preferences for rat and mouse MHC class I molecules using random peptide libraries.

Authors:  J Stevens; K H Wiesmüller; P Walden; E Joly
Journal:  Eur J Immunol       Date:  1998-04       Impact factor: 5.532

6.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.

Authors:  J Hammer; F Gallazzi; E Bono; R W Karr; J Guenot; P Valsasnini; Z A Nagy; F Sinigaglia
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

7.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

8.  Promiscuous and allele-specific anchors in HLA-DR-binding peptides.

Authors:  J Hammer; P Valsasnini; K Tolba; D Bolin; J Higelin; B Takacs; F Sinigaglia
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

9.  Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.

Authors:  Anna Lobell; Robert Weissert; Sana Eltayeb; Katrien L de Graaf; Judit Wefer; Maria K Storch; Hans Lassmann; Hans Wigzell; Tomas Olsson
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

10.  Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year.

Authors:  Lawrence Steinman
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  3 in total

1.  Experimental Antiglomerular Basement Membrane GN Induced by a Peptide from Actinomyces.

Authors:  Qiu-Hua Gu; Megan Huynh; Yue Shi; Xiao-Yu Jia; Jie-Jian Luo; Tai-Jiao Jiang; Zhao Cui; Joshua D Ooi; A Richard Kitching; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2020-06       Impact factor: 10.121

2.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

Authors:  Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

3.  An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology.

Authors:  Leszek A Rybaczyk; Meredith J Bashaw; Dorothy R Pathak; Scott M Moody; Roger M Gilders; Donald L Holzschu
Journal:  BMC Womens Health       Date:  2005-12-20       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.